LUNG Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 5.70%

Insider Buying (Last 12 Months): $97,435.80

Insider Selling (Last 12 Months): $1,647,504.66

Pulmonx Insider Trading History Chart

Pulmonx Share Price & Price History

^$7.45

▲ +0.395 (5.60%)

As of 03/14/2025 03:41 PM ET

Days: 30 | 90 | 365

Pulmonx Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
3/3/2025	David Aaron Lehman	General Counsel	Sell	22,355	$7.65	$171,015.75	175,496
3/3/2025	Geoffrey Beran Rose	Insider	Sell	5,779	$7.13	$41,204.27	285,278
3/3/2025	Mehul Joshi	CFO	Sell	14,384	$7.12	$102,414.08	113,986
3/3/2025	Steven S Williamson	CEO	Sell	27,689	$7.14	$197,699.46	194,342
2/20/2025	Glendon E. French, III	Director	Sell	55,453	$8.28	$459,150.84	1,011,974
1/16/2025	Glendon E. French, III	Director	Sell	2,326	$6.53	$15,188.78	1,069,648
12/2/2024	David Aaron Lehman	General Counsel	Sell	5,497	$6.19	$34,026.43	197,851
12/2/2024	Geoffrey Beran Rose	Insider	Sell	4,376	$6.18	$27,043.68	291,057
11/22/2024	Glendon E. French, III	Director	Sell	20,000	$6.63	$132,600.00	1,071,974
10/17/2024	Glendon E. French, III	Director	Sell	20,000	$6.52	$130,400.00	1,091,974
9/12/2024	Glendon E. French, III	Director	Sell	20,000	$8.09	$161,800.00	1,111,974
9/3/2024	David Aaron Lehman	General Counsel	Sell	5,765	$6.69	$38,567.85	203,348
9/3/2024	Geoffrey Beran Rose	Insider	Sell	4,586	$6.70	$30,726.20	295,433
8/20/2024	Steven S Williamson	CEO	Buy	14,245	$6.84	$97,435.80	219,531
6/24/2024	Geoffrey Beran Rose	Insider	Sell	1,184	$6.16	$7,293.44	300,019
6/3/2024	David Aaron Lehman	General Counsel	Sell	5,475	$6.97	$38,160.75	209,113
6/3/2024	Geoffrey Beran Rose	Insider	Sell	4,297	$6.97	$29,950.09	301,203
5/22/2024	Geoffrey Beran Rose	Insider	Sell	1,184	$8.71	$10,312.64	305,500
4/22/2024	Geoffrey Beran Rose	Insider	Sell	1,184	$7.49	$8,868.16	306,684
3/22/2024	Geoffrey Beran Rose	Insider	Sell	1,184	$9.36	$11,082.24	307,868
3/1/2024	David Aaron Lehman	General Counsel	Sell	4,351	$9.06	$39,420.06	145,488
3/1/2024	Geoffrey Beran Rose	Insider	Sell	3,097	$9.06	$28,058.82	239,952
3/1/2024	Glendon E. French, III	CEO	Sell	6,954	$9.06	$63,003.24	1,116,758
3/1/2024	John Mckune	CFO	Sell	1,078	$9.06	$9,766.68	47,410
2/22/2024	Geoffrey Beran Rose	Insider	Sell	1,184	$14.20	$16,812.80	243,049
2/15/2024	Glendon E. French, III	CEO	Sell	20,000	$14.60	$292,000.00	1,121,344
1/22/2024	Geoffrey Beran Rose	Insider	Sell	1,184	$13.13	$15,545.92	244,233
1/18/2024	Glendon E. French, III	CEO	Sell	10,000	$12.77	$127,700.00	1,141,344
12/22/2023	Geoffrey Beran Rose	Insider	Sell	1,184	$12.75	$15,096.00	245,417
12/21/2023	Glendon E. French, III	CEO	Sell	10,000	$12.42	$124,200.00	1,151,344
12/1/2023	David Aaron Lehman	General Counsel	Sell	3,809	$10.34	$39,385.06	149,839
12/1/2023	Geoffrey Beran Rose	Insider	Sell	2,868	$10.34	$29,655.12	246,601
12/1/2023	Glendon E. French, III	CEO	Sell	6,676	$10.34	$69,029.84	1,161,344
12/1/2023	John Mckune	CFO	Sell	942	$10.34	$9,740.28	40,414
11/22/2023	Geoffrey Beran Rose	Insider	Sell	1,184	$10.60	$12,550.40	249,469
10/23/2023	Geoffrey Beran Rose	Insider	Sell	1,184	$8.35	$9,886.40	250,653
9/22/2023	Geoffrey Beran Rose	Insider	Sell	1,184	$10.51	$12,443.84	251,837
9/1/2023	David Aaron Lehman	General Counsel	Sell	3,772	$10.01	$37,757.72	153,648
9/1/2023	Derrick Sung	CFO	Sell	4,219	$10.00	$42,190.00	391,041
9/1/2023	Geoffrey Beran Rose	Insider	Sell	2,843	$10.01	$28,458.43	253,021
9/1/2023	Glendon E. French, III	CEO	Sell	6,527	$10.01	$65,335.27	1,168,020
8/23/2023	Geoffrey Beran Rose	Insider	Sell	1,184	$10.54	$12,479.36	255,864
7/20/2023	Glendon E. French, III	CEO	Sell	15,000	$12.68	$190,200.00	1,174,547
6/15/2023	Glendon E. French, III	CEO	Sell	10,000	$12.68	$126,800.00	1,189,547
6/1/2023	David Aaron Lehman	General Counsel	Sell	3,776	$11.48	$43,348.48	157,420
6/1/2023	Derrick Sung	CFO	Sell	4,222	$11.49	$48,510.78	395,260
6/1/2023	Geoffrey Beran Rose	Insider	Sell	2,845	$11.48	$32,660.60	257,048
6/1/2023	Glendon E. French, III	CEO	Sell	6,533	$11.48	$74,998.84	1,199,547
3/1/2023	Derrick Sung	CFO	Sell	1,264	$11.03	$13,941.92	261,482
3/1/2023	Geoffrey Beran Rose	Insider	Sell	1,206	$11.03	$13,302.18	180,993
3/1/2023	Glendon E. French, III	CEO	Sell	2,895	$11.03	$31,931.85	1,032,580
12/1/2022	David Aaron Lehman	General Counsel	Sell	1,069	$5.93	$6,339.17	44,160
12/1/2022	Geoffrey Beran Rose	Insider	Sell	1,055	$5.93	$6,256.15	181,037
12/1/2022	Glendon E. French, III	CEO	Sell	3,631	$5.93	$21,531.83	1,034,313
11/29/2022	Alissa Hsu Lynch	Director	Buy	1,700	$5.51	$9,367.00	11,910
11/8/2022	Richard Ferrari	Director	Buy	5,438	$5.31	$28,875.78	30,035
9/15/2022	Glendon E. French, III	CEO	Sell	25,000	$20.00	$500,000.00	1,027,944
8/18/2022	Glendon E. French, III	CEO	Sell	50,000	$20.59	$1,029,500.00	1,055,884
6/1/2022	David Aaron Lehman	General Counsel	Sell	1,065	$18.05	$19,223.25	46,311
6/1/2022	Geoffrey Beran Rose	Insider	Sell	1,011	$18.05	$18,248.55	183,118
6/1/2022	Glendon E. French, III	CEO	Sell	2,523	$18.05	$45,540.15	1,104,994

See Full Table

SEC Filings (Institutional Ownership Changes) for Pulmonx (NASDAQ:LUNG)

91.04% of Pulmonx stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Pulmonx Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
2/27/2025	Jefferies Financial Group Inc.	285,110	$1.94M	0.0%	-0.4%	0.722%
2/20/2025	Mackenzie Financial Corp	54,823	$0.37M	0.0%	N/A	0.139%
2/17/2025	Squarepoint Ops LLC	91,455	$0.62M	0.0%	-24.5%	0.232%
2/17/2025	Two Sigma Advisers LP	90,000	$0.61M	0.0%	-5.2%	0.228%
2/17/2025	ProShare Advisors LLC	10,669	$72K	0.0%	N/A	0.027%
2/17/2025	Millennium Management LLC	183,069	$1.24M	0.0%	+26.6%	0.464%
2/17/2025	Jacobs Levy Equity Management Inc.	83,370	$0.57M	0.0%	-72.3%	0.211%
2/17/2025	Graham Capital Management L.P.	18,071	$0.12M	0.0%	+73.3%	0.046%
2/17/2025	D. E. Shaw & Co. Inc.	392,836	$2.67M	0.0%	+8.9%	0.995%
2/17/2025	Deutsche Bank AG	1,100,989	$7.48M	0.0%	-1.9%	2.788%
2/17/2025	Deerfield Management Company L.P. Series C	1,534,763	$10.42M	0.2%	N/A	3.886%
2/17/2025	Bridgeway Capital Management LLC	62,900	$0.43M	0.0%	-7.9%	0.159%
2/17/2025	Bank of America Corp DE	55,237	$0.38M	0.0%	+58.8%	0.140%
2/17/2025	BNP Paribas Financial Markets	6,265	$43K	0.0%	N/A	0.016%
2/14/2025	Mercer Global Advisors Inc. ADV	82,070	$0.56M	0.0%	N/A	0.208%
2/14/2025	PDT Partners LLC	49,378	$0.34M	0.0%	-43.9%	0.125%
2/14/2025	Schonfeld Strategic Advisors LLC	135,500	$0.92M	0.0%	-29.0%	0.343%
2/14/2025	Northern Trust Corp	372,659	$2.53M	0.0%	+2.9%	0.944%
2/14/2025	Tudor Investment Corp ET AL	149,102	$1.01M	0.0%	+9.0%	0.378%
2/14/2025	Birchview Capital LP	51,000	$0.35M	0.3%	N/A	0.129%
2/14/2025	Boothbay Fund Management LLC	212,980	$1.45M	0.0%	-22.9%	0.539%
2/14/2025	Susquehanna Fundamental Investments LLC	61,405	$0.42M	0.0%	N/A	0.155%
2/14/2025	Price T Rowe Associates Inc. MD	33,585	$0.23M	0.0%	-21.9%	0.085%
2/14/2025	Rock Springs Capital Management LP	772,151	$5.24M	0.2%	+11.7%	1.955%
2/14/2025	Stifel Financial Corp	11,900	$81K	0.0%	N/A	0.030%
2/14/2025	Dimensional Fund Advisors LP	408,022	$2.77M	0.0%	+17.4%	1.033%
2/14/2025	Altium Capital Management LLC	815,000	$5.53M	1.6%	+63.0%	2.064%
2/13/2025	XTX Topco Ltd	21,555	$0.15M	0.0%	N/A	0.055%
2/13/2025	Barclays PLC	66,511	$0.45M	0.0%	-29.3%	0.168%
2/13/2025	Renaissance Technologies LLC	220,510	$1.50M	0.0%	+38.7%	0.558%
2/13/2025	ADAR1 Capital Management LLC	28,221	$0.19M	0.0%	N/A	0.071%
2/13/2025	Russell Investments Group Ltd.	20,017	$0.14M	0.0%	-45.0%	0.051%
2/13/2025	Wells Fargo & Company MN	18,418	$0.13M	0.0%	+48.7%	0.047%
2/12/2025	ExodusPoint Capital Management LP	48,047	$0.33M	0.0%	-36.1%	0.122%
2/12/2025	Trexquant Investment LP	93,700	$0.64M	0.0%	+510.1%	0.237%
2/12/2025	Geode Capital Management LLC	902,240	$6.13M	0.0%	+1.1%	2.285%
2/12/2025	Franklin Resources Inc.	576,273	$3.91M	0.0%	-17.7%	1.459%
2/12/2025	Pura Vida Investments LLC	387,200	$2.63M	8.3%	-24.0%	0.981%
2/12/2025	Norges Bank	151,200	$1.03M	0.0%	N/A	0.383%
2/12/2025	JPMorgan Chase & Co.	768,430	$5.22M	0.0%	-27.2%	1.946%
2/11/2025	Vanguard Group Inc.	2,283,459	$15.51M	0.0%	+0.2%	5.782%
2/11/2025	American Century Companies Inc.	34,738	$0.24M	0.0%	+8.8%	0.088%
2/10/2025	Primecap Management Co. CA	5,512,291	$37.43M	0.0%	-2.9%	13.959%
2/10/2025	Connor Clark & Lunn Investment Management Ltd.	83,941	$0.57M	0.0%	+44.8%	0.213%
2/6/2025	Charles Schwab Investment Management Inc.	315,532	$2.14M	0.0%	+0.8%	0.799%
1/30/2025	Rhumbline Advisers	53,503	$0.36M	0.0%	+4.9%	0.135%
1/23/2025	R Squared Ltd	6,763	$46K	0.0%	N/A	0.017%
1/17/2025	SG Americas Securities LLC	15,555	$0.11M	0.0%	+27.0%	0.039%
12/26/2024	JPMorgan Chase & Co.	1,055,522	$8.75M	0.0%	+2.4%	2.673%
12/5/2024	272 Capital LP	5,730	$48K	0.0%	N/A	0.015%
11/27/2024	Franklin Resources Inc.	700,389	$5.81M	0.0%	+2.3%	1.774%
11/19/2024	Barclays PLC	94,109	$0.78M	0.0%	+1.8%	0.238%
11/16/2024	Geode Capital Management LLC	892,786	$7.40M	0.0%	+1.3%	2.261%
11/15/2024	Barclays PLC	94,109	$0.78M	0.0%	+1.8%	0.238%
11/15/2024	State Street Corp	747,028	$6.19M	0.0%	+2.6%	1.892%
11/15/2024	Polar Asset Management Partners Inc.	107,684	$0.89M	0.0%	N/A	0.273%
11/15/2024	Parkman Healthcare Partners LLC	206,444	$1.71M	0.2%	N/A	0.523%
11/15/2024	Jacobs Levy Equity Management Inc.	301,361	$2.50M	0.0%	-38.5%	0.763%
11/15/2024	Atom Investors LP	19,389	$0.16M	0.0%	-82.6%	0.049%
11/14/2024	272 Capital LP	3,000	$25K	0.0%	N/A	0.008%
11/14/2024	PFM Health Sciences LP	368,929	$3.06M	0.2%	N/A	0.934%
11/14/2024	PDT Partners LLC	88,074	$0.73M	0.1%	+25.3%	0.223%
11/13/2024	Millrace Asset Group Inc.	167,725	$1.39M	1.4%	N/A	0.425%
11/13/2024	FMR LLC	5,872,882	$48.69M	0.0%	+11.2%	14.872%
11/12/2024	Charles Schwab Investment Management Inc.	313,169	$2.60M	0.0%	+5.2%	0.793%
11/9/2024	Primecap Management Co. CA	5,676,011	$47.05M	0.0%	-0.6%	14.373%
11/8/2024	BNP PARIBAS ASSET MANAGEMENT Holding S.A.	1,114,297	$9.24M	0.0%	+5.2%	2.822%
11/8/2024	Connor Clark & Lunn Investment Management Ltd.	57,953	$0.48M	0.0%	N/A	0.147%
11/5/2024	GSA Capital Partners LLP	64,771	$0.54M	0.0%	N/A	0.165%
10/16/2024	nVerses Capital LLC	3,100	$26K	0.0%	N/A	0.008%
10/3/2024	SG Americas Securities LLC	12,245	$0.10M	0.0%	N/A	0.032%
9/16/2024	Cubist Systematic Strategies LLC	109,105	$0.69M	0.0%	+141.6%	0.281%
9/16/2024	Point72 Asia Singapore Pte. Ltd.	5,855	$37K	0.0%	N/A	0.015%
8/19/2024	Point72 Asset Management L.P.	240,949	$1.53M	0.0%	-91.1%	0.621%
8/16/2024	Algert Global LLC	20,939	$0.13M	0.0%	-63.6%	0.054%
8/15/2024	Susquehanna Fundamental Investments LLC	75,260	$0.48M	0.0%	N/A	0.194%
8/15/2024	Mackenzie Financial Corp	16,124	$0.10M	0.0%	N/A	0.042%
8/15/2024	Millennium Management LLC	448,623	$2.84M	0.0%	-31.0%	1.156%
8/15/2024	Deerfield Management Company L.P. Series C	47,539	$0.30M	0.0%	+134.3%	0.122%
8/15/2024	AQR Capital Management LLC	11,059	$70K	0.0%	-81.5%	0.028%
8/15/2024	Point72 Asia Singapore Pte. Ltd.	5,855	$37K	0.0%	N/A	0.015%
8/14/2024	Squarepoint Ops LLC	144,409	$0.92M	0.0%	+261.2%	0.372%
8/14/2024	Cubist Systematic Strategies LLC	109,105	$0.69M	0.0%	+141.6%	0.281%
8/12/2024	XTX Topco Ltd	34,968	$0.22M	0.0%	N/A	0.090%
8/12/2024	Hsbc Holdings PLC	15,038	$93K	0.0%	N/A	0.039%
8/10/2024	Sofinnova Investments Inc.	60,246	$0.38M	0.0%	N/A	0.155%
8/9/2024	Primecap Management Co. CA	5,709,901	$36.20M	0.0%	-0.5%	14.710%
8/9/2024	Renaissance Technologies LLC	301,410	$1.91M	0.0%	+13.1%	0.777%
8/9/2024	Dimensional Fund Advisors LP	345,074	$2.19M	0.0%	-12.8%	0.889%
8/5/2024	Victory Capital Management Inc.	834,301	$5.29M	0.0%	+1.0%	2.149%
7/30/2024	BNP PARIBAS ASSET MANAGEMENT Holding S.A.	1,059,018	$6.71M	0.0%	+7.0%	2.728%
7/26/2024	Bank of New York Mellon Corp	157,902	$1M	0.0%	+12.7%	0.407%
5/16/2024	California State Teachers Retirement System	34,733	$0.32M	0.0%	-4.9%	0.089%
5/16/2024	Jacobs Levy Equity Management Inc.	197,336	$1.83M	0.0%	-45.9%	0.508%
5/15/2024	Price T Rowe Associates Inc. MD	35,720	$0.33M	0.0%	+4.8%	0.092%
5/14/2024	EntryPoint Capital LLC	11,013	$0.10M	0.1%	N/A	0.028%
5/10/2024	Vanguard Group Inc.	2,077,859	$19.26M	0.0%	+0.6%	5.391%
5/8/2024	BNP PARIBAS ASSET MANAGEMENT Holding S.A.	989,423	$9.17M	0.0%	+6.4%	2.567%
5/8/2024	Russell Investments Group Ltd.	34,947	$0.32M	0.0%	-41.1%	0.091%
5/7/2024	Sei Investments Co.	72,626	$0.67M	0.0%	+2.5%	0.188%

Data available starting January 2016

See Full Table

Pulmonx Corporation, a commercial-stage medical technology company, provides minimally invasive devices for the treatment of chronic obstructive pulmonary diseases. The company offers Zephyr Endobronchial Valve, a solution for the treatment of patients with hyperinflation associated with severe emphysema; and Chartis Pulmonary Assessment System, a balloon catheter and console system with flow and pressure sensors that are used to assess the presence of collateral ventilation. It also offers StratX Lung Analysis Platform, a cloud-based quantitative computed tomography analysis service that offers information on emphysema destruction, fissure completeness, and lobar volume to help identify target lobes for the treatment with Zephyr Valves. The company serves emphysema patients in the United States, Europe, the Middle East, Africa, the Asia-Pacific, and internationally. The company was formerly known as Pulmonx and changed its name to Pulmonx Corporation in December 2013. Pulmonx Corporation was incorporated in 1995 and is headquartered in Redwood City, California.

Today's Range

Now: $7.45

$7.04

$7.41

50 Day Range

MA: $7.00

$5.68

$9.20

52 Week Range

Now: $7.45

$5.46

$10.01

Volume

90,076 shs

Average Volume

332,534 shs

Market Capitalization

$296.28 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.5

Who are the company insiders with the largest holdings of Pulmonx?: Pulmonx's top insider investors include:
Glendon E French III (CEO)
Glendon E French III (Director)
Derrick Sung (CFO)
Geoffrey Beran Rose (Insider)
Steven S Williamson (CEO)
David Aaron Lehman (General Counsel)
Mehul Joshi (CFO)
John Mckune (CFO)
Learn More about top insider investors at Pulmonx.
Who are the major institutional investors of Pulmonx?: Pulmonx's top institutional investors include:
Primecap Management Co. CA — 13.96%
Vanguard Group Inc. — 5.78%
Deerfield Management Company L.P. Series C — 3.89%
Deutsche Bank AG — 2.79%
Geode Capital Management LLC — 2.28%
Altium Capital Management LLC — 2.06%
Learn More about top institutional investors of Pulmonx stock.
Which major investors are selling Pulmonx stock?: In the last quarter, LUNG stock was sold by these institutional investors:
JPMorgan Chase & Co.
Jacobs Levy Equity Management Inc.
Primecap Management Co. CA
Franklin Resources Inc.
Pura Vida Investments LLC
Boothbay Fund Management LLC
Schonfeld Strategic Advisors LLC
PDT Partners LLC
During the last year, company insiders that have sold Pulmonx company stock include:
Glendon E French III (CEO)
Glendon E French III (Director)
Derrick Sung (CFO)
Geoffrey Beran Rose (Insider)
Steven S Williamson (CEO)
Learn More investors selling Pulmonx stock.
Which major investors are buying Pulmonx stock?: During the last quarter, LUNG stock was purchased by institutional investors including:
Deerfield Management Company L.P. Series C
Altium Capital Management LLC
Norges Bank
Mercer Global Advisors Inc. ADV
Rock Springs Capital Management LP
Trexquant Investment LP
Renaissance Technologies LLC
Susquehanna Fundamental Investments LLC